SAN DIEGO, Jan. 07, 2022 (GLOBE NEWSWIRE) -- Sorrento Therapeutics,
Inc. (Nasdaq: SRNE, "Sorrento") today announced the unexpected passing
of Mr. Najjam Asghar, Chief Financial Officer and Senior Vice President.
Mr. Asghar died of apparent natural causes on January 6, 2022.
"Sorrento
is deeply saddened and shocked by the loss of our dear friend and
colleague. Our immediate thoughts go to Najjam’s family and friends,"
said Dr. Henry Ji, Sorrento's Chairman and CEO. “We appreciate and thank
Najjam for his tremendous contributions to Sorrento and the San Diego
life sciences community.”
Mr. Asghar joined Sorrento in June 2019
from NuVasive, Inc., where he served as VP, Accounting and Finance since
October 2015. At Sorrento, Mr. Asghar served as Chief Financial
Officer, leading the functions of Finance, Accounting and Tax. Mr.
Asghar started his career with PricewaterhouseCoopers, where he served
various S&P 100 and S&P 500 clients in North America and Asia in
the audit and assurance practice. Mr. Asghar received his Bachelor’s
degree in Accounting from the University of Punjab, Pakistan.
Sorrento does not expect that Mr. Asghar’s passing will have an impact on its ongoing or planned business.